Ken Griffin Iridex Corp Transaction History

Citadel Advisors LLC

$618 Billion
Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Iridex Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 109,473 shares of IRIX stock, worth $107,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,473

Previous 36,100 203.25%

Holding current value

$107,283

Previous $31,000 303.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.89 - $1.53 $69,688 - $119,802	78,302 Added 251.2%	109,473 $125,000
Q2 2025 Aug 14, 2025	SELL	$0.85 - $1.3 $36,615 - $56,000	-43,077 Reduced 58.02%	31,171 $27,000
Q1 2025 May 15, 2025	BUY	$0.8 - $1.78 $5,276 - $11,739	6,595 Added 9.75%	74,248 $73,000
Q4 2024 Feb 14, 2025	BUY	$1.39 - $1.93 $24,154 - $33,537	17,377 Added 34.56%	67,653 $115,000
Q3 2024 Nov 14, 2024	BUY	$1.75 - $2.15 $15,606 - $19,173	8,918 Added 21.56%	50,276 $87,000

Q2 2024 Aug 14, 2024	BUY	$1.97 - $3.53 $4,842 - $8,676	2,458 Added 6.32%	41,358 $89,000
Q1 2024 May 15, 2024	BUY	$2.35 - $3.1 $74,892 - $98,793	31,869 Added 453.26%	38,900 $115,000
Q4 2023 Feb 14, 2024	BUY	$1.9 - $3.28 $13,170 - $22,736	6,932 Added 7002.02%	7,031 $19,000
Q3 2023 Nov 14, 2023	SELL	$1.33 - $2.54 $14,554 - $27,795	-10,943 Reduced 99.1%	99 $0
Q2 2023 Aug 14, 2023	SELL	$1.76 - $2.43 $2,078 - $2,869	-1,181 Reduced 9.66%	11,042 $23,000
Q1 2023 May 15, 2023	BUY	$2.0 - $2.46 $5,980 - $7,355	2,990 Added 32.38%	12,223 $24,000
Q4 2022 Feb 14, 2023	BUY	$2.0 - $2.63 $18,466 - $24,282	9,233 New	9,233 $18,000

Others Institutions Holding IRIX

# of Institutions

Shares Held

2.84M

Call Options Held

Put Options Held

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $15.7M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account